Miller Value Partners’s Halozyme HALO Stock Holding History

Miller Value Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$355K	–	79
2019 Q4	$355K	Hold	20,000	–	–	0.01%	85
2019 Q3	$310K	Hold	20,000	–	–	0.01%	86
2019 Q2	$344K	Hold	20,000	–	–	0.01%	88
2019 Q1	$322K	Hold	20,000	–	–	0.01%	90
2018 Q4	$293K	Sell	20,000 -150,000	-88%	-$2.39M	0.01%	87
2018 Q3	$3.09M	Hold	170,000	–	–	0.1%	70
2018 Q2	$2.87M	Hold	170,000	–	–	0.11%	69
2018 Q1	$3.33M	Hold	170,000	–	–	0.14%	62
2017 Q4	$3.44M	Hold	170,000	–	–	0.15%	60
2017 Q3	$2.95M	Sell	170,000 -779,800	-82%	-$10.6M	0.13%	64
2017 Q2	$12.2M	Buy	+949,800	New	+$12.7M	0.49%	35

Other funds holding HALO

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Miller Value Partners's HALO Position: Q1 2020 in Review

Miller Value Partners sold out of Halozyme (HALO) in Q1 2020, closing a stake of 20,000 shares — an estimated $355K sold.

Miller Value Partners first reported a position in HALO in Q2 2017 and held it in 11 quarters. The position peaked at $12.2M in Q2 2017. 210 funds tracked by Wall St. Rank hold HALO as of Q1 2020.

Miller Value Partners reported no remaining Halozyme position as of Q1 2020 after selling out during the quarter.
Miller Value Partners sold 20,000 Halozyme shares in Q1 2020, an estimated $355K.
Miller Value Partners first reported a position in Halozyme in Q2 2017 and held it in 11 quarters.
Miller Value Partners's Halozyme position peaked at $12.2M in Q2 2017.
210 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.

Based on Miller Value Partners's 13F filing for Q1 2020, filed 15 May 2020.